Pre-IPO Hebei Titans Medical Supply Technology Group - Insights on the Business and the Concerns
231 Views07 Oct 2021 08:55
The article analyzed Titans in terms of its the industry characteristics (the development pattern, the outlook), the business (compared with peers) and the concerns (overcapacity, raw materials cost).
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
- Intco Medical Technology (300677.CH) - Declining Performance & Overcapacity Indicate Gloomy Outlook01 Jun 2022
- Pre-IPO Top Glove Corp - The Good Times Brought by COVID-19 Are Slipping Away23 Mar 2022
- Pre-IPO Huayuan Medical Group Holding - How to Tell a Good Story After the COVID-19 Magic Disappear?17 Nov 2021
- Pre-IPO Hebei Titans Medical Supply Technology Group - Insights on the Business and the Concerns07 Oct 2021
- Pre-IPO Abbisko Cayman - It Still Takes Some Time for Commercialization21 Jul 2021
- Pre-IPO MicroPort MedBot - The Core Products, the Business Model and the Concerns13 Jul 2021
- Pre-IPO Intco Medical Technology - Economies of Scale or Overcapacity?14 Apr 2021
x